Challenges of anticoagulant therapy in patients with atrial fibrillation in clinical practice.

Challenges of anticoagulant therapy in patients with atrial fibrillation in clinical practice.

Bibliographic Details
Main Author:	Hobbs, R
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Anticoagulant management in patients with atrial fibrillation.
by: Fitzmaurice, D, et al.
Published: (2009)

Challenges of stroke prevention in patients with atrial fibrillation in clinical practice.
by: Hobbs, F, et al.
Published: (2011)

ANTICOAGULATION IN PATIENTS WITH ATRIAL-FIBRILLATION - EXPERT SOFTWARE MAY BE THE ANSWER
by: Fitzmaurice, D, et al.
Published: (1994)

Underuse of anticoagulation for atrial fibrillation - are we failing our patients?
by: Jones, N, et al.
Published: (2017)

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
by: van Walraven, C, et al.
Published: (2009)

Atrial fibrillation – NICE 2021 update and the focus on anticoagulation
by: Jones, N, et al.
Published: (2022)

Time trends in atrial fibrillation-associated stroke and premorbid anticoagulation
by: Yiin, G, et al.
Published: (2018)

Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.
by: Wan, Y, et al.
Published: (2008)

An updated meta-analysis on the clinical outcomes of percutaneous left atrial appendage closure versus direct oral anticoagulation in patients with atrial fibrillation
by: Jiang, Haowen, et al.
Published: (2023)

Treatment pathways for patients with atrial fibrillation.
by: Hodgkinson, J, et al.
Published: (2012)

A systematic review of economic aspects of service interventions to increase anticoagulation use in atrial fibrillation
by: Jones, NR, et al.
Published: (2021)

Using machine learning to predict anticoagulation control in atrial fibrillation: a UK Clinical Practice Research Datalink study
by: Gordon, J, et al.
Published: (2021)

Atrial fibrillation and bisphosphonate therapy.
by: Pazianas, M, et al.
Published: (2010)

Research into practice: management of atrial fibrillation in general practice.
by: Fitzmaurice, D, et al.
Published: (2014)

Identification and treatment of patients with atrial fibrillation in primary care.
by: Hobbs, R
Published: (1999)

Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants
by: Beshir, Semira Abdi, et al.
Published: (2017)

Stroke prevention in atrial fibrillation
by: Hobbs, F
Published: (2003)

Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?
by: Sandercock, P, et al.
Published: (1986)

Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.
by: Holt, T, et al.
Published: (2012)

Rhythm control agents and adverse events in patients with atrial fibrillation.
by: Taylor, C, et al.
Published: (2010)

The clinical epidemiology of atrial fibrillation in a population cohort and methods to identify those at risk of atrial fibrillation
by: Gardezi, S
Published: (2019)

Atrial fibrillation: is screening effective in identifying patients at risk of stroke?
by: McCahon, D, et al.
Published: (2014)

Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?
by: Mant, J, et al.
Published: (2008)

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.
by: De Caterina, R, et al.
Published: (2012)

Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia
by: Beshir, S.A., et al.
Published: (2016)

Should we screen for atrial fibrillation?
by: Lown, M, et al.
Published: (2017)

Mechanisms of atrial fibrillation
by: Wijesurendra, RS, et al.
Published: (2019)

Screening for atrial fibrillation: A call for evidence
by: Jones, N, et al.
Published: (2019)

Potential pharmacological therapies for atrial fibrillation. A computational study
by: Sánchez, C, et al.
Published: (2010)

Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
by: Chan, Kevin E., et al.
Published: (2016)

Improving antithrombotic management in patients with atrial fibrillation: current status and perspectives.
by: Levi, M, et al.
Published: (2009)

Long term follow up of direct oral anticoagulants and warfarin therapy on stroke, with all-cause mortality as a competing risk, in people with atrial fibrillation: sentinel network database study
by: de Lusignan, S, et al.
Published: (2022)

Improving the diagnosis of heart failure in patients with atrial fibrillation
by: Bunting, KV, et al.
Published: (2021)

Early management of atrial fibrillation in general surgical in-patients
by: Walsh, SR, et al.
Published: (2006)

An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.
by: Apenteng, P, et al.
Published: (2013)

Targeted atrial fibrillation detection in COVID-19 vaccination clinics
by: Ford, GA, et al.
Published: (2021)

The Clinical Outcome Evaluation On The Atrial Fibrillation Patients Receiving Warfarin For Secondary Stroke Prevention In The Medication Therapy Adherence Clinic In Serdang And Seremban Hospitals
by: Mochamad Djunaedi, Mochamad Djunaedi
Published: (2016)

Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
by: Mavaddat, N, et al.
Published: (2014)

Atrial fibrillation and the use of oral bisphosphonates.
by: Pazianas, M, et al.
Published: (2011)

Triggers for new-onset atrial fibrillation in critically ill patients
by: Bedford, J, et al.
Published: (2021)